Finzati - Logo
BDRX logo

Biodexa Pharmaceuticals Plc

BDRX • Biotechnology
$0.85
▲ +0.05 (+6.21%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$38,388.55
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 2.03Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 27, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.85
Change6.21%
Shares Out45.16K
Market Cap$38.39K
52W Range2.45 - 66.50
Beta1.22
P/E-0.02
P/S0.00
P/B0.01
P/FCF-0.02
EV/Sales0.00
EV/EBITDA0.99

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 2.03Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 12/7/2015
Industry: Biotechnology
P/B i: 0.01
Debt / Equity i: 0.01
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 2.03
Quick Ratio: 2.03
Status: Good

Insider Transactions

Recent executive and insider activity

Parker Stephen Barry
Transaction: 03/18/2026
OTHER
Change
+576
Price
$475.00
Filing
03/20/2026
Type
OTHER
Turton Simon
Transaction: 03/18/2026
OTHER
Change
+288
Price
$475.00
Filing
03/18/2026
Type
OTHER
Turton Simon
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/18/2026
Type
OTHER